Search alternatives:
significantly increased » significant increase (Expand Search)
increased decrease » increased release (Expand Search), increased crash (Expand Search)
point decrease » point increase (Expand Search)
part decrease » bfrt decreased (Expand Search), a decrease (Expand Search), pa decreased (Expand Search)
Showing 741 - 760 results of 13,613 for search '(( significantly increased decrease ) OR ( significant ((part decrease) OR (point decrease)) ))*', query time: 0.57s Refine Results
  1. 741
    Growth of certain cancer cell lines requires IRE1 but not its enzymatic activity.

    Growth of certain cancer cell lines requires IRE1 but not its enzymatic activity. by Iratxe Zuazo-Gaztelu (21071939)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 742
    IRE1 depletion downregulates multiple cell cycle proteins in synchronized cells.

    IRE1 depletion downregulates multiple cell cycle proteins in synchronized cells. by Iratxe Zuazo-Gaztelu (21071939)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 743
    IRE1 depletion induces cell cycle arrest independently of apoptosis.

    IRE1 depletion induces cell cycle arrest independently of apoptosis. by Iratxe Zuazo-Gaztelu (21071939)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 744
    Growth of certain cancer cell lines requires IRE1 but not its enzymatic activity.

    Growth of certain cancer cell lines requires IRE1 but not its enzymatic activity. by Iratxe Zuazo-Gaztelu (21071939)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 745
    IRE1 silencing downregulates cell cycle genes and engages TP53 and specific CDK inhibitors.

    IRE1 silencing downregulates cell cycle genes and engages TP53 and specific CDK inhibitors. by Iratxe Zuazo-Gaztelu (21071939)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 746
    IRE1 silencing downregulates cell cycle genes and engages TP53 and specific CDK inhibitors.

    IRE1 silencing downregulates cell cycle genes and engages TP53 and specific CDK inhibitors. by Iratxe Zuazo-Gaztelu (21071939)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 747
    Pharmacological efficacy of Kylo-0603 in MASH mouse models (F2 ~ 3).

    Pharmacological efficacy of Kylo-0603 in MASH mouse models (F2 ~ 3). by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 748
    General procedure for the synthesis of B.

    General procedure for the synthesis of B. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 749
    The trends of gene expression in the metabolism of triglycerides in liver tissue.

    The trends of gene expression in the metabolism of triglycerides in liver tissue. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 750
    After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group.

    After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 751
    The trends of cholesterol metabolism-related gene expression in liver tissue.

    The trends of cholesterol metabolism-related gene expression in liver tissue. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 752
    Kylo-0603’s EC50 & tissue levels.

    Kylo-0603’s EC50 & tissue levels. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 753
    The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention.

    The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 754
    The trends in the expression of inflammation-related genes in liver tissue.

    The trends in the expression of inflammation-related genes in liver tissue. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 755
    The Fibrosis scoring by Sirius Red staining and SHG/TPEF.

    The Fibrosis scoring by Sirius Red staining and SHG/TPEF. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 756
    Effects of Kylo-0603 on body weight, organ weight, and body fat content.

    Effects of Kylo-0603 on body weight, organ weight, and body fat content. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 757
    The trends in the expression of fibrosis-related genes in liver tissue.

    The trends in the expression of fibrosis-related genes in liver tissue. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 758
    Effects of Kylo-0603 on the expression of related genes of the MASH mouse models.

    Effects of Kylo-0603 on the expression of related genes of the MASH mouse models. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 759
    Plasma cholesterol and LDL-C levels.

    Plasma cholesterol and LDL-C levels. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 760
    General procedure for the synthesis of A and A-c1.

    General procedure for the synthesis of A and A-c1. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: